Researchers: here's how olive oil (and its oleocanthal phenol) can affect processes related to Alzheimer's

Initial note: this article has been previously published and updated according to scientific and informative criteria. The information is for informational purposes only and does not replace medical advice.

IN BRIEF

• Oleocanthal is a phenolic molecule found in some extra virgin olive oils that, in experimental models, interacts with processes related to amyloid-β and tau.
• Studies on cells and animals indicate that oleocanthal can promote the removal of amyloid-β and modulate tau protein fibrillization, but these data remain preclinical. [1][2][3]
• Dietary interventions that include EVOO (extra-virgin olive oil) show favorable effects on cognitive function in human trials, but the direct responsibility of a single compound has not been demonstrated. [8]
• The most robust evidence is preclinical and mechanistic: controlled clinical studies are needed to establish efficacy, dose, and safety in humans. [4][5][6][7][9]

Abstract: what does science say?

Oleocanthal is a phenol found in varying concentrations in extra virgin olive oil and has been studied for its anti-inflammatory and anti-aggregative properties. Experiments on cell cultures and murine models have shown that oleocanthal can increase the removal of amyloid-β through blood-brain barrier transporters and interfere with the formation of tau aggregates. These results partly explain why Mediterranean diets rich in EVOO are associated with better cognitive function in population studies; however, the transition from preclinical evidence to clinical recommendations is not direct. The final effect depends on variables such as the oil's phenol content, the quantity consumed, the overall dietary pattern, age, and individual risk factors. Current evidence is promising but does not prove that oleocanthal alone prevents or cures Alzheimer's.

Proposed biological mechanisms

Experimental research identifies more than one mechanism through which oleocanthal could affect processes associated with Alzheimer's. In cellular and animal models, increased expression and activity of proteins involved in the transport and removal of amyloid-β from the brain region to the circulation, such as P-gp and LRP1, have been observed; this has been linked to a reduction in cerebral amyloid-β accumulation in preclinical studies. [1]

In parallel, oleocanthal shows anti-aggregation activity against the tau protein: biochemical experiments indicate that it can interfere with fibril formation through chemical reactions with amino acid residues of the protein, limiting its conformational transition to β-sheet structures typical of pathological aggregates. [2][3]

Other reported effects include anti-inflammatory properties and modulation of cellular pathways such as autophagy and inflammation components (e.g., NLRP3): these collective mechanisms can contribute to improved brain homeostasis in experimental models. [5]

Experimental evidence and models

Much of the evidence on oleocanthal comes from in vitro studies (nerve cells, blood-brain barrier endothelial cells) and transgenic murine models that reproduce some aspects of Alzheimer's pathology. In several experiments, oleocanthal reduces amyloid-β load and attenuates markers of brain inflammation; similar effects have been observed after administration of purified oleocanthal or EVOO rich in this phenol. [1][4][5]

Studies using human blood-brain barrier models in vitro and animals show an increase in amyloid-β clearance and an improvement in barrier permeability in the presence of oleocanthal or phenol-rich EVOO. However, the exact translation of doses and administration methods from animals to humans remains uncertain. [4][5]

Recent research has also compared EVOO with low oleocanthal content and enriched preparations, highlighting differences in the effect on neuropathological markers in mice: these comparisons help to separate the effect of the single compound from the overall contribution of the food matrix. [6][7]

Clinical and population evidence

To understand the impact on humans, it is useful to distinguish between observational data, dietary interventions, and controlled studies. Population studies and some reviews show associations between adherence to the Mediterranean diet (which includes regular use of EVOO) and less cognitive decline in the medium term; in a randomized clinical trial on an elderly population, the addition of EVOO to the Mediterranean diet was associated with better cognitive scores compared to the control. [8]

However, these trials evaluate an overall dietary pattern and not the effect of a single phenol; therefore, it is not possible to directly attribute the outcomes solely to oleocanthal. Some pilot studies exploring the safety and possible signs of efficacy of high-phenolic EVOO in people with mild cognitive impairment are ongoing and have recently been published, but the evidence remains preliminary. [5][6][7][9]

What it means in practice

For the general public, the central message is that extra virgin olive oil, as a component of a balanced Mediterranean-style diet, is associated with cardiovascular benefits and favorable signals for cognitive health at the population level. The individual compounds present in the oil, including oleocanthal, offer plausible mechanistic explanations for these associations, but this is not proof that oleocanthal alone prevents or cures Alzheimer's.

Reasonable nutritional practices include preferring quality oils (EVOO) within a varied diet rich in vegetables, fruits, whole grains, legumes, fish, and with limited ultra-processed foods. Any dietary choice should still be evaluated in a personal context (co-existing pathologies, pharmacological therapies, energy requirements) in consultation with healthcare professionals.

KEY POINTS TO REMEMBER

• Oleocanthal is a phenolic component of EVOO studied for its anti-aggregative and anti-inflammatory properties. [1][2][3]
• The most solid data are preclinical: cells and animal models show reductions in amyloid-β and tau modulation. [1][2][3][4]
• Dietary interventions with EVOO show cognitive benefits at the population level, but do not establish the causality of a single compound. [8]
• There is currently no definitive clinical evidence that oleocanthal, taken alone, prevents or cures Alzheimer's in humans. [4][6][7]

Limitations of the evidence

It is important to clarify the difference between observation, biological plausibility, and causal proof. Observational studies show associations: for example, greater adherence to the Mediterranean diet is associated with less cognitive decline over time, but these studies cannot prove that a single food or compound is the causal factor. [8]

Experimental studies (in vitro and in animals) allow for the exploration of mechanisms and possible molecular targets (e.g., P-gp, LRP1, tau modifications, NLRP3), but animal models do not fully reproduce the complexity of human Alzheimer's. Differences in dosage, bioavailability, and metabolism between species limit the direct applicability of the results. [1][2][3][4][5]

There are also variabilities in the quality and phenolic content of extra virgin olive oils: not all EVOOs contain the same amount of oleocanthal, and the effect of a single compound can be influenced by the food matrix and interactions with other nutrients. [6][9]

Methodological diversity

Many studies are small, short-term, or not randomized; surrogate measures (biochemical markers, plaques in tissue) do not always translate into lasting clinical changes in cognitive function. This requires caution in interpreting promising results as proof of clinical efficacy. [4][5][7]

Prudent interpretation

In light of the limitations, prudent interpretation is necessary: the evidence supports a plausible role of EVOO and its phenols in promoting brain health, but does not authorize therapeutic or prescriptive claims regarding oleocanthal as a treatment for Alzheimer's. [1][3][8]

Editorial conclusion

The body of evidence—mechanistic, preclinical, and some population data—indicates that components of extra virgin olive oil, including oleocanthal, can contribute to biological processes relevant to the onset and progression of neurodegenerative diseases. However, the complexity of the disease, the differences between animal and human studies, and the lack of clinical trials targeting single compounds necessitate caution. For the public, the most solid approach remains a varied diet based on public health evidence (e.g., the Mediterranean model), while the scientific community must continue to rigorously test the doses, forms, and safety of specific extracts in controlled clinical trials.

Editorial note

This version is an informative update prepared with editorial criteria of transparency and source verification. The content does not replace medical advice. For specific questions about diet or treatments, consult a qualified healthcare professional.

SCIENTIFIC RESEARCH

1. Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies. ACS Chem Neurosci. 2013;4(6):973–982. https://doi.org/10.1021/cn400024q
2. Li W, Sperry JB, Crowe A, Trojanowski JQ, Smith AB, Lee VM. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J Neurochem. 2009;110(4):1339–1351. https://doi.org/10.1111/j.1471-4159.2009.06224.x
3. Monti MC, Margarucci L, Riccio R, Casapullo A. Modulation of tau protein fibrillization by oleocanthal. J Nat Prod. 2012;75(9):1584–1588. https://doi.org/10.1021/np300384h
4. Qosa H, Mohamed LA, Batarseh YS, et al. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chem Neurosci. 2015. https://doi.org/10.1021/acschemneuro.5b00190
5. Al Rihani SB, Darakjian LI, Kaddoumi A. Oleocanthal-rich extra-virgin olive oil restores the blood–brain barrier function through NLRP3 inflammasome inhibition simultaneously with autophagy induction in TgSwDI mice. J Agric Food Chem. 2019;67(14):3845–3853. https://doi.org/10.1021/acs.jafc.8b06723
6. Comparison of Oleocanthal-Low EVOO and Oleocanthal against Amyloid-β and Related Pathology in a Mouse Model of Alzheimer’s Disease. Molecules. 2023;28(3):1249. https://doi.org/10.3390/molecules28031249
7. Yang E, Wang J, Woodie LN, Greene MW, Kaddoumi A. Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer’s Disease. Molecules. 2023;28:5592. https://doi.org/10.3390/molecules28145592
8. Valls-Pedret C, Sala-Vila A, Serra-Mir M, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094–1103. https://doi.org/10.1001/jamainternmed.2015.1668
9. Review—Neuroprotective Effects of Olive Oil Phenolics. Antioxidants. 2024;13(7):762. https://doi.org/10.3390/antiox13070762

Note: the listed research has been selected for its relevance to the topic and is accompanied by a verifiable DOI. If interested in individual articles, it is recommended to consult the primary sources for methodological details.